Dashboard
Manage Tickers

ARCT


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
CSL and Arcturus Therapeutics Announce Nat...
05/20/2024 12:42:20

Data follow the approval of the world's first self-amplifying (sa-mRNA) COVID-19 vaccine for adults in Japan. These results...

canaccord-genuity-maintains-buy-on-arcturus-therapeutics-lowers-price-target-to-86
Canaccord Genuity Maintains Buy on Arcturu...
05/10/2024 18:30:57

Canaccord Genuity analyst Whitney Ijem maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and lowers the price target ...

elon-musk-breaks-ranks-with-gop-by-praising-genetic-engineering-tech-that-helped-fight-covid-19-digital-medicine-with-incredible-potential
Elon Musk Breaks Ranks With GOP By Praisin...
05/09/2024 09:01:47

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

arcturus-therapeutics-q1-eps-100-beats-119-estimate-sales-3801m-beat-1754m-estimate
Arcturus Therapeutics Q1 EPS $(1.00) Beats...
05/08/2024 20:03:35

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(1.00) per share which beat the analyst consensus estimate of...

hc-wainwright--co-reiterates-buy-on-arcturus-therapeutics-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Arct...
03/20/2024 10:44:28

HC Wainwright & Co. reiterates Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and maintains $60 price target.

the-analyst-verdict-arcturus-therapeutics-in-the-eyes-of-4-experts
The Analyst Verdict: Arcturus Therapeutics...
03/11/2024 12:01:29

canaccord-genuity-maintains-buy-on-arcturus-therapeutics-raises-price-target-to-87
Canaccord Genuity Maintains Buy on Arcturu...
03/11/2024 11:51:35

Canaccord Genuity analyst Whitney Ijem maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and raises the price target ...

hc-wainwright--co-reiterates-buy-on-arcturus-therapeutics-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Arct...
03/08/2024 14:42:42

HC Wainwright & Co. analyst Ed Arce reiterates Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and maintains $60 price ta...

recap-arcturus-therapeutics-q4-earnings
Recap: Arcturus Therapeutics Q4 Earnings
03/07/2024 21:05:07

arcturus-therapeutics-q4-2023-gaap-eps-0320-beats-0760-estimate-sales-33989m-miss-37856m-estimate
Arcturus Therapeutics Q4 2023 GAAP EPS $(0...
03/07/2024 21:03:49

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.320) per share which beat the analyst consensus estimate o...

earnings-scheduled-for-march-7-2024
Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

earnings-preview-arcturus-therapeutics
Earnings Preview: Arcturus Therapeutics
03/06/2024 15:01:58

arcturus-therapeutics-receives-orphan-medicinal-product-designation-from-the-european-commission-for-arct-032-for-treatment-of-cystic-fibrosis
Arcturus Therapeutics Receives Orphan Medi...
02/22/2024 13:33:35

citigroup-maintains-buy-on-arcturus-therapeutics-raises-price-target-to-48
Citigroup Maintains Buy on Arcturus Therap...
02/08/2024 16:04:52

Citigroup analyst Yigal Nochomovitz maintains Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and raises the price target fro...

arcturus-therapeutics-announces-new-covid-19-sa-mrna-results
Arcturus Therapeutics Announces New COVID-...
02/05/2024 13:31:59

Short communication follows previously published data in The Lancet Infectious Diseases demonstrating Immunological Non-Inferio...

logitech-posts-q3-results-joins-coinbase-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Logitech Posts Q3 Results, Joins Coinbase ...
01/23/2024 10:04:19

U.S. stock futures were mostly lower this morning, with the Dow futures falling around 20 points on Tuesday.

csl-and-arcturus-therapeutics-announced-the-publication-in-lancet-infectious-diseases-of-a-phase-3-study-showing-that-a-booster-dose-of-arct-154-meet-the-non-inferiority-criteria
CSL And Arcturus Therapeutics Announced Th...
12/21/2023 13:14:31

Data follow approval of the world's first Self-Amplifying messenger RNA (sa-mRNA) COVID-19 Vaccine for Adults by Japan Mini...

arcturus-therapeutics-lung-disease-candidate-triggers-bullish-rating-analyst-sees-over-200-upside
Arcturus Therapeutics' Lung Disease Candid...
12/13/2023 18:34:47

Canaccord Genuity has initiated coverage on Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT), a player in the genetic medicine...

canaccord-genuity-initiates-coverage-on-arcturus-therapeutics-with-buy-rating
Canaccord Genuity Initiates Coverage On Ar...
12/13/2023 09:35:31

Canaccord Genuity analyst Whitney Ijem initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Buy rating.

5-value-stocks-in-the-healthcare-sector
5 Value Stocks In The Healthcare Sector
12/04/2023 14:44:10

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION